State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha 410082, China.
Analyst. 2018 Jul 23;143(15):3579-3585. doi: 10.1039/c8an01008k.
Light-up aptamers have attracted growing attention due to their advantages of being label-free and having low fluorescence background. In this work, we developed a light-up fluorescence assay for label-free detection of tumor cells based on a bifunctional split aptamer (BFSA) that contained two DNA strands (BFSA-a and BFSA-b). BFSA-a and BFSA-b were constructed by combining aptamers ZY11 and ThT.2-2, which could specifically bind to the tumor cell SMMC-7721 and activate the fluorescence of thioflavin T (ThT). A Helper strand was introduced to hybridize with BFSA-b, and then BFSA-a and BFSA-b were separated if the target cell was absent. Only when the target cell is present can BFSA-a approach and hybridize with BFSA-b due to the 'induced-fit effect', which made the Helper strand dissociate. Then ThT bound to BFSA and the fluorescence of ThT was activated. The results indicated that this fluorescence assay had a good linear response to the target cells in the range of 250-20 000 cells in 100 μL binding buffer; the lowest cell number actually detected was 125 cells in 100 μL buffer. This assay also displayed excellent selectivity and was successfully applied to detect target cells in 20% human serum samples. The design of bifunctional split aptamers realized no-washing, label-free, low-cost, one-step detection of tumor cells, which could generate detectable fluorescence signals just by mixing nucleic acid aptamers and fluorescent reporter molecules with target cells. Such a design of aptamer probes also has the potential to construct stimuli-responsive controlled drug delivery systems.
由于无标记且荧光背景低,发光适体受到越来越多的关注。在这项工作中,我们开发了一种基于双功能分裂适体(BFSA)的无标记荧光检测肿瘤细胞的方法,BFSA 由两条 DNA 链(BFSA-a 和 BFSA-b)组成。BFSA-a 和 BFSA-b 通过结合 ZY11 和 ThT.2-2 构建,这两种适体可以特异性结合肿瘤细胞 SMMC-7721 并激活硫黄素 T(ThT)的荧光。引入了一条辅助链与 BFSA-b 杂交,如果不存在靶细胞,则 BFSA-a 和 BFSA-b 会分离。只有当存在靶细胞时,由于“诱导契合效应”,BFSA-a 才能接近并与 BFSA-b 杂交,这使得辅助链解离。然后,ThT 与 BFSA 结合,激活 ThT 的荧光。结果表明,该荧光分析方法在 100μL 结合缓冲液中对 250-20000 个目标细胞具有良好的线性响应;实际上在 100μL 缓冲液中检测到的最低细胞数为 125 个细胞。该测定法还表现出优异的选择性,并成功应用于检测 20%人血清样品中的靶细胞。双功能分裂适体的设计实现了无洗涤、无标记、低成本、一步检测肿瘤细胞,只需将核酸适体和荧光报告分子与靶细胞混合即可产生可检测的荧光信号。这种适体探针的设计还有望构建刺激响应型可控药物输送系统。